-
New research indicates that use of the contraceptive patch results in greater cost savings and reductions in pregnancy, compared with combination oral contraceptives, due to improved compliance by patients.
-
-
The Food and Drug Administration (FDA) has issued an alert concerning use of unapproved home-use diagnostic test kits marketed over the Internet.
-
New research indicates that lower bone density appears to recover in adolescent females once they stop using the contraceptive injection depot medroxyprogesterone acetate (DMPA, Depo Provera, Pfizer, New York City).
-
The 12-lead ECG in the Figure was obtained from a 75-year-old woman who presented with shortness of breath but no chest pain. There is complete RBBB (right bundle branch block). What else do you see? In view of this clinical presentation, what should you be concerned about?
-
A review of 79 clinical trials involving diet plus medications for treating obesity with BMI > 27 found modest weight loss at 1 year with sibutramine, orlistat, phentermine, bupropion, and topiramate when compared to placebo pills, and probably also for diethylpropion and fluoxetine.
-
-
Recent guidance from the United States Preventive Services Task Force has affirmed the evidence-based value of screening male current/ex-smokers older than age 65 for abdominal aortic aneurysm.
-
The FDA has approved the combination of isosorbide dinitrate and hydralazine for the treatment of heart failure in the black (African decent) population.
-
Understanding of etiologies, management, and outcomes of febrile neutropenia has improved in recent years, and it is now possible to identify patients at high risk for morbidity and mortality using demographic, historical, and laboratory indicators.